##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 84 Download : 67

##plugins.themes.academic_pro.article.main##

Abstract

Hypertensive disorder of pregnancy is one of the most common complications in pregnancy forming a triad together with hemorrhage and infection. It affects about 10% of pregnancies and contributes for a significant maternal and perinatal mortality.

Keywords

Von Willebrand Doppler Findings Pregnancy Hypertensive Disorders

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Zaman Farhan Mohammed, & Israa Hashim Abid-Alkareem. (2022). The Relation Between von Willebrand Factor Plasma Concentration and Ultrasonograohic Doppler Findings in Pregnancies Complicated by Hypertensive Disorders. Texas Journal of Medical Science, 7, 41–46. https://doi.org/10.62480/tjms.2022.vol7.pp41-46
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Sultana S, Yasmin T, Mollah MN, Roy SK, Hossain MS, Al-Amin A. Duplex color doppler study of uterine artery in early diagnosis of preeclampsia. Bangladesh Medical Research Council Bulletin. 2019 Jun 15;45(1):34-40.
  2. Chen X, Zhou J, Xu L, Chen L, Mao P, Yang X. Serological ferritin, 100A12, procalcitonin and APACHEII score in prediction the prognosis of acute respiratory distress syndrome. Pteridines. 2019 Feb 1;30(1):165-70.
  3. Elnabtity AM, Selim MF. Norepinephrine versus ephedrine to maintain arterial blood pressure during spinal anesthesia for cesarean delivery: A prospective double-blinded trial. Anesthesia, essays and researches. 2018 Jan;12(1):92.
  4. Marin JR, Abo AM, Arroyo AC, Doniger SJ, Fischer JW, Rempell R, Gary B, Holmes JF, Kessler DO, Lam SH, Levine MC. Pediatric emergency medicine point-of-care ultrasound: summary of the evidence. Critical ultrasound journal. 2016 Dec;8(1):16.
  5. Panchal S, Nagori C. Color Doppler in Obstetrics & Gynecology. Jaypee Brothers, Medical Publishers Pvt. Limited; 2019 Mar 31.
  6. Fadal Allah SM. Study of Umbilical Arteries in Diabetic Mothers using Doppler (Doctoral dissertation, Sudan University of Science & Technology).
  7. Bartoli CR, Zhang DM, Hennessy-Strahs S, Kang J, Restle DJ, Bermudez C, Atluri P, Acker MA. Clinical and in vitro evidence that left ventricular assist device–induced von Willebrand factor degradation alters angiogenesis. Circulation: Heart Failure. 2018 Sep;11(9):e004638.
  8. Randi AM, Laffan MA, Starke RD: Von Wil¬lebrand factor, angiodysplasia and angiogen¬esis. Mediterr J Hematol Infect Dis 2013; 5:e2013060.
  9. Qin F, Impeduglia T, Schaffer P, Dardik H: Overexpression of von Willebrand factor is an independent risk factor for pathogenesis of intimal hyperplasia: preliminary studies. J Vasc Surg 2003; 37: 433–439.
  10. Soares AL, Kazmi RS, Borges MA, Rosario PW, Fernandes AP, Sousa MO, Lwaleed BA, Carvalho MG: Elevated plasma factor VIII and von Willebrand factor in women with type 2 diabetes: inflammatory reaction, endo¬thelial perturbation or else?. Blood Coagul Fi¬brinolysis 2011; 22: 600–605.
  11. Molvarec A, Szarka A, Walentin S, Szucs E, Nagy B, Rigó J Jr: Circulating angiogenic fac¬tors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia. Hypertens Res 2010; 33: 892–898.
  12. Triunfo S, Crovetto F, Crispi F, Rodriguez- Sureda V, Dominguez C, Nadal A, Peguero A, Gratacos E, Figueras F: Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclamp¬sia. Placenta 2016; 42: 44–50.
  13. Szpera-Gozdziewicz A, Gozdziewicz T, Boruczkowski M, Dworacki G, Breborowicz GH. Relationship between the von Willebrand Factor Plasma Concentration and Ultrasonographic Doppler Findings in Pregnancies Complicated by Hypertensive Disorders: A Pilot Study. Gynecologic and obstetric investigation. 2018;83(3):252-8.
  14. Xiang Y, Hwa J: Regulation of VWF expres¬sion, and secretion in health and disease. Curr Opin Hematol 2016; 23: 288–293.
  15. Saboor M, Moinuddin, Ajmal M, Ilyas S: Functional status of vascular endothelium in diabetes mellitus. J Ayub Med Coll Abbot¬tabad 2014; 26: 239–243.
  16. Levy GG, Motto DG, Ginsburg D: AD¬AMTS13 turns 3. Blood 2005; 106: 11–17.
  17. Miura M, Kaikita K, Matsukawa M, Soejima K, Fuchigami S, Miyazaki Y, Ono T, Uemura T, Tsujita K, Hokimoto S, Sumida H, Sugi¬yama S, Matsui K, Yamabe H, Ogawa H: Prog¬nostic value of plasma von Willebrand factor-cleaving protease (ADAMTS13) antigen lev¬els in patients with coronary artery disease. Thromb Haemost 2010; 103: 623–629.
  18. Bongers TN, de Bruijne EL, Dippel DW, de Jong AJ, Deckers JW, Poldermans D, de Maat MP, Leebeek FW: Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients. Atherosclerosis 2009; 207: 250–254.
  19. Gombos T, Makó V, Cervenak L, et al: Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (AD¬AMTS13) activity predict clinical events in chronic heart failure. Thromb Haemost 2009; 102: 573–580.
  20. Feys HB, Canciani MT, Peyvandi F, Deckmyn H, Vanhoorelbeke K, Mannucci PM: AD-AMTS13 activity to antigen ratio in physio¬logical and pathological conditions associated with an increased risk of thrombosis. Br J Haematol 2007; 138: 534–540.
  21. Chion CK, Doggen CJ, Crawley JT, Lane DA, Rosendaal FR: ADAMTS13 and von Wille¬brand factor and the risk of myocardial in¬farction in men. Blood 2007; 109: 1998–2000.
  22. Bongers TN, de Maat MP, van Goor ML, Bhagwanbali V, van Vliet HH, Gomez Garcia EB, Dippel DW, Leebeek FW: High von Wil¬lebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, in¬flammation, and genetic variability. Stroke 2006; 37: 2672–2677.
  23. Andersson HM, Siegerink B, Luken BM, Crawley JT, Algra A, Lane DA, Rosendaal FR: High VWF, low ADAMTS13, and oral con¬traceptives increase the risk of ischemic stroke and myocardial infarction in young women. Blood 2012; 119: 1555–1560.
  24. Sonneveld MA, de Maat MP, Portegies ML, Kavousi M, Hofman A, Turecek PL, Rotten¬steiner H, Scheiflinger F, Koudstaal PJ, Ikram MA, Leebeek FW: Low ADAMTS13 activity is associated with an increased risk of ischemic stroke. Blood 2015; 126: 2739– 2746.